Back to glossary
Therapeutics

Humanin

Humanin is a 24-amino-acid mitochondrial-derived peptide encoded in the 16S rRNA region of mtDNA, originally identified by Hashimoto and Nishimoto in surviving neurons of Alzheimer brains. In cell and rodent models it is anti-apoptotic (binds Bax, IGFBP-3) and neuroprotective against amyloid-β toxicity, and circulating humanin declines with age in mice, macaques, and humans. There is no approved indication for humanin or its analogues anywhere in the world as of 2026; all evidence is preclinical or observational, with no completed phase-3 human efficacy trial. Synthetic humanin and analogues such as HNG circulate as research peptides only.

Sources

  1. Hashimoto Y, Niikura T, Tajima H, et al.. (2001). A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. *Proceedings of the National Academy of Sciences*doi:10.1073/pnas.101133498
  2. Yen K, Wan J, Mehta HH, et al.. (2020). The mitochondrial-derived peptide humanin is a regulator of lifespan and healthspan. *Aging (Aging-US)*doi:10.18632/aging.103534
  3. Lee C, Wan J, Miyazaki B, et al.. (2014). IGF-1 regulates the age-dependent signaling peptide humanin. *Aging Cell*